Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220206 · ClinicalTrials.gov registry record · Phase 2
POMx In the Treatment of Erectile Dysfunction
A Phase 2 study, sponsored by POM Wonderful.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT01220206 is a Phase 2 study that has completed, run by POM Wonderful. The registered enrollment target is 120 participants.
The verdict
NCT01220206, a Phase 2 study, has completed, sponsored by POM Wonderful.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
POMx can be used as a treatment for erectile dysfunction.
Interventions
- DRUG Placebo
- DRUG One POMx capsule daily
- DRUG 2 POMx Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01220206
The ClinicalTrials.gov registry entry for NCT01220206 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POM Wonderful, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01220206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01220206 about?
NCT01220206 is a clinical study titled "POMx In the Treatment of Erectile Dysfunction". POMx can be used as a treatment for erectile dysfunction.
What is the current status of trial NCT01220206?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2011-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01220206?
The interventions under investigation include: Placebo (DRUG), One POMx capsule daily (DRUG), 2 POMx Capsules (DRUG).
Who is sponsoring clinical trial NCT01220206?
This trial is sponsored by POM Wonderful, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.